Previous Article | Next Article ![]()
Infection and Immunity, July 2001, p. 4502-4508, Vol. 69, No. 7
Department of Basic and Clinical Immunology,
Finlay Institute, Havana City, Cuba
Received 11 September 2000/Returned for modification 24 October
2000/Accepted 28 March 2001
This report explores the participation of some afferent mechanisms
in the immune response induced by the Cuban anti-meningococcal vaccine
VA-MENGOC-BC. The induction of delayed-type hypersensitivity in nursing
babies and lymphocyte proliferation after immunization is demonstrated.
The presence of gamma interferon IFN-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4502-4508.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Immune Response Induction and New Effector
Mechanisms Possibly Involved in Protection Conferred by the Cuban
Anti-Meningococcal BC Vaccine
and interleukin-2 (IL-2) mRNAs
but absence of IL-4, IL-5, and IL-10 mRNAs were observed in peripheral
blood mononuclear cells from immunized subjects after in vitro
challenge with outer membrane vesicles. In addition, some effector
functions were also explored. The presence of opsonic activity was
demonstrated in sera from vaccinees. The role of neutrophils as
essential effector cells was shown. In conclusion, we have shown that,
at least in the Cuban adult population, VA-MENGOC-BC induces mechanisms
with a T-helper 1 pattern in the afferent and effector branches of the
immune response.
*
Corresponding author. Mailing address: Department of
Basic and Clinical Immunology, Finlay Institute, P.O. Box 16017, Havana City, Cuba. Phone: 53 (7) 217597 or 53 (7) 218321. Fax: 53 (7) 286075. E-mail: oliverp{at}finlay.edu.cu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|